Clinical Trial Update: An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal Hypertension [Phase 2]

View source ↗

Summary

Phase 2 exploratory haemodynamic study in patients with compensated cirrhosis and portal hypertension. Results were posted in January 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Portal Hypertension

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Compensated Cirrhosis and Portal Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2016-01-20